Cargando…
Exposing drug industry funding of UK patient organisations
Drug company payment disclosures have limited transparency, but Piotr Ozieranski and colleagues find that they are increasing in value and are targeted at select patient organisations
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group Ltd.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529850/ https://www.ncbi.nlm.nih.gov/pubmed/31122928 http://dx.doi.org/10.1136/bmj.l1806 |